Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01823653 · ClinicalTrials.gov registry record · NA
Treatment of Subcutaneous Adipose Tissue in the Thighs Using High Intensity Focused Ultrasound
A NA study of Treatment of Adipose Tissue in the Thighs, sponsored by Solta Medical.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 4
- Study locations
NCT01823653 is a NA study of Treatment of Adipose Tissue in the Thighs that has completed, run by Solta Medical. The registered enrollment target is 60 participants. The trial reports 4 study locations across 4 states.
The verdict
NCT01823653, a NA study of Treatment of Adipose Tissue in the Thighs, has completed, sponsored by Solta Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to assess the safety and efficacy of treatment with the Liposonix System (Model 2) for the circumferential reduction of subcutaneous adipose tissue (SAT) of the thighs.
Conditions Studied
Interventions
- DEVICE Liposonix System (Model 2)
Study Locations (4)
Arizona
- Van Dyke Laser and Skin - Paradise Valley
California
- Solta Medical Aesthetic Center - Hayward
Oregon
- Jewell Plastic Surgery Center - Eugene
Ontario
- Solish M.D. - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-07 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01823653
The ClinicalTrials.gov registry entry for NCT01823653 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Solta Medical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Treatment of Adipose Tissue in the Thighs appearing as the primary indexed condition, and to 1 intervention - of which Liposonix System (Model 2) is the first listed.
NCT01823653 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Arizona, California, Oregon.
Frequently Asked Questions
What is clinical trial NCT01823653 about?
NCT01823653 is a clinical study titled "Treatment of Subcutaneous Adipose Tissue in the Thighs Using High Intensity Focused Ultrasound". The purpose of this study is to assess the safety and efficacy of treatment with the Liposonix System (Model 2) for the circumferential reduction of subcutaneous adipose tissue (SAT) of the thighs.
What is the current status of trial NCT01823653?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2012-07. Estimated completion is 2013-01.
What conditions does trial NCT01823653 study?
This clinical trial studies the following conditions: Treatment of Adipose Tissue in the Thighs.
What interventions are being tested in trial NCT01823653?
The interventions under investigation include: Liposonix System (Model 2) (DEVICE).
Who is sponsoring clinical trial NCT01823653?
This trial is sponsored by Solta Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01823653 being conducted?
This trial has 4 study locations across Arizona, California, Oregon, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.